SL1002

· Saol Therapeutics Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SL1002, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain [Phase 3]